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Abstract
Hydrogel nanomaterials, especially those that are of non-human and non-animal origins, have
great potential in biomedical and pharmaceutical sciences due to their versatility and inherent
soft-tissue like properties. With the ability to simulate native tissue function, hydrogels are
potentially well suited for cellular therapy applications. In this study, we have fabricated nanofi-
brillar cellulose-alginate (NFCA) suture coatings as biomedical devices to help overcome some
of the limitations related to cellular therapy, such as low cell survivability and distribution out of
target tissue. The addition of sodium alginate 8% (w/v) increased the NFCA hydrogel viscosity,
storage and loss moduli by slightly under one order of magnitude, thus contributing significantly
to coating strength. Confocal microscopy showed nearly 100% cell viability throughout the 2-
week incubation period within and on the surface of the coating. Additionally, typical morpholo-
gies in the dual cell culture of spheroid forming HepG2 and monolayer type SK-HEP-1 were
observed. Twelve out of 14 NFCA coated surgical sutures remained intact during the suturing
operation with various mice and rat tissue; however, partial peeling off was observed in 2 of the
coated sutures. We conclude that NFCA suture coatings could perform as cell-carrier systems
for cellular based therapy and post-surgical treatment.
Introduction
Classic biomaterials and biomedical devices are widely used and well established in combina-
tion with surgery and post-surgical treatment today [1]. However, recent developments have
introduced new treatment strategies and possibilities, such as controlled and localized drug
delivering sutures [2], and stem cell transplanting sutures [3,4]. These biomedical devices have
great potential in improving patient treatment and recovery. However, it has been reported
that there are some risks related to administering cells in current fashion, e.g. injections, or
seeding the suture, can cause unwanted cell aggregation, in addition to cells migrating and dis-
tributing to undesired tissues and low cell survivability due to a lack of protection against the
mechanical stress of the suturing itself [4,5]. Additionally, while the seeding of cells within the
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surgical thread could be improved by increasing the amount of microthreads in the fold [3],
the total number of cells could still be limited by the surface area of the thread. Some of these
limitations could be circumvented with the entrapment of cells within a protective layer, such
as a hydrogel coating.
Hydrogel nanomaterials and nanocomposites have recently gained increasing interest in
modern medicine, including biomedical and pharmaceutical applications as well as tissue
engineering [6]. Nanofibrillar cellulose (NFC) is one of these materials [7,8], with versatility
and inherent properties that have led to studies that utilize NFC hydrogels as a biomedical
material, such as a scaffold that promotes three-dimensional cell culture or a drug-releasing
matrix [9–14]. NFC fibers have inherent similarity to collagen fibers [9,15], great modification
capabilities [16,17], high water content, pseudoplastic and thixotropic properties [18], and are
considered as a biocompatible and non-toxic biomaterial [19–20]. Similarly to NFC, alginate is
a widely studied biopolymer, known to be biocompatible, non-toxic and frequently used in tis-
sue engineering [21–23]. Alginate is a linear polysaccharide found in species of brown algae,
and forms gels in the presence of divalent ions [24], such as calcium and barium, where the
positively charged ions can bind with the negatively charged glucuronic acid blocks. Alginate
has been the most recognized material for cell encapsulation [25,26], while providing immune
protection and allowing good metabolic functionality in a 3D culturing environment [27–29].
In addition, NFC hydrogel and alginate composition has been used in bioprinting [30], where
it was reported that the addition of NFC improved the hydrogel structural fidelity, preventing
the collapse of printed shapes. The shear thinning characteristics of NFC and alginate [9,31],
are particularly desirable features, as they enable hydrogel injectability, and thus, the fabrica-
tion of nanocomposite NFCA threads and suture coatings.
In this study, we have employed a method of producing nanofibrillar cellulose-alginate
hydrogels (NFCA) in the form of threads and suture coatings for potential applications in cel-
lular therapy. The fabricated NFCA suture coatings are an improvement to our groups previ-
ous glutaraldehyde cross-linked, slightly more brittle, threads [32], and might offer a solution
to some of the limitations and risks related to cell delivery by acting as a cell-carrier system
without the need for additional injections or separate cell transplantation procedures. Sutures
could be placed at the target site while retaining cells within the coating matrix reducing cell
distribution to unwanted tissues and functioning as a protective layer against the mechanical
stress induced by the suturing process to improve cell survivability.
We have investigated the rheological properties of the NFCA hydrogels in addition to cell
viability and suturing performance of the NFCA coated sutures on various tissues of rat and
mouse. Cell studies were performed with HepG2 (cluster type) and SK-HEP-1 (monolayer
type) cell lines as a co-culture model for carrying cells to the target site within the suture coat-
ing and on the surface respectively. Potential applications for such NFCA hydrogels are: cell-
carrier systems including oral mucosa repair [33,34], ulcer treatment [35,36], and for example
Crohn’s disease, which has been recently investigated in treatment of fistulas with adipose-
derived stem cells [37–39], where cell transplantations were done with separate injections at
the sutured internal openings of the fistulas. Additionally, cell co-culture systems enable differ-
ent cell types to be utilized in a single treatment system [40], or a model that can be utilized in
studies evaluating treatment efficiencies [41].
Materials & methods
NFCA thread preparation
NFC hydrogel and alginate mixtures were prepared to produce NFCA threads. Sodium algi-
nate powder (Sigma-Aldrich, W201502, Finland) was added and mixed briefly with the stock
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NFC hydrogel (1.47% NFC, GrowDex1, UPM-Kymmene Corporation, Finland). After mix-
ing, the mixture was left to stabilize for 24 hours. The final composition of NFCA prepared for
cell studies and suturing performance tests contained 8% (w/v) sodium alginate and 1.35%
(w/v) NFC hydrogel. The NFCA threads were prepared by dispensing the mixture with a
syringe and a 22G needle into calcium chloride (CaCl2, anhydrous, Riedel-de-Haen, Germany)
and barium chloride (BaCl2
 2H2O, Sigma-Aldrich, Finland) crosslinking solutions (68 mM
and 20 mM respectively). Alginate crosslinking method used in this study was implemented
from an alginate-based cell microencapsulation study performed by one of our group previ-
ously [42].
NFCA rheology
Rheological measurements were done with Haake™ Viscotester™ iQ Rheometer (ThermoFischer,
Germany) using 2˚ cone-plate geometry. Plate diameter was 35 mm and the gap was set to 0.1
mm. Experiments were done at 25˚C with peltier temperature controlled system. Oscillatory
stress amplitude sweeps were performed to determine sample linear visco-elastic regions
(110−4–500 Pa at the frequency of 1 Hz). The effect of frequency on storage and loss moduli
was measured with a frequency sweep (0.1–20 Hz at constant amplitudes of 8 and 12 Pa for
native NFC and NFCA respectively), and the viscosity was measured with the controlled rate
mode (0.1–1000 1/s). Sample materials for rheological experiments included 1.35% (w/v) NFC
hydrogel mixtures with 3 different amounts (7, 8 or 9% (w/v)) of sodium alginate. All measure-
ments were replicated 3 times and averages shown with their respective standard deviations.
Cell lines
Human hepatocellular carcinoma HepG2 (ATCC1 HB-8065™, USA) and human adenocarci-
noma-derived endothelial SK-HEP-1 cells (ATCC1 HTB-52™, USA) were cultured in high
glucose Dulbecco’s modified Eagle’s medium (DMEM, Gibco™, Scotland) supplemented with
10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine and
100 mM sodium pyruvate. Cell cultures were maintained in 37˚C and 5% CO2 until 70–80%
confluence before detachment and preparation of cell suspensions. HepG2 cells were used as a
model type for 3D cell organoids, and SK-HEP-1 cells for epithelial 2D monolayer culture.
NFCA thread cell seeding and culturing
HepG2 cells were detached, centrifuged and suspended within the NFCA mixture. The
NFCA-HepG2 mixture contained 1043 cells/μl (150 μl) and the final concentrations were 8%
and 1.35% of sodium alginate and NFC respectively. NFCA crosslinking was performed by
extruding the NFCA-HepG2 mixture through a 22G-size needle into a 68 mM calcium chlo-
ride solution and incubated for 3 minutes. The produced thread-like structures were trans-
ferred into a 20 mM barium chloride solution for additional 5 minutes. Calcium chloride and
barium chloride crosslinking stabilized the hydrogel-thread structure to withstand handling in
its wet state. Afterwards the threads (n = 5) were transferred into non-treated 6-well culture
plates with 2 ml of full cell-culture medium and incubation was carried out at 37˚C and in 5%
CO2. Cell culture medium exchange was performed every 48 hours.
NFCA thread cell surface and co-cultures
To enable co-culturing, the prepared NFCA-HepG2 threads were treated with Type-I collagen
to enhance surface adhesion (Rat Collagen I (LV) 3 mg/ml, Cultrex1, Trevigen, USA). The
collagen working solution was prepared according to the manufacturer’s guidelines with
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DMEM replacing water to dilute the stock solution. The concentration of Type-I collagen in
the working solution was 1 mg/ml. The collagen working solution (300–500 μl) was pipetted
on the NFCA or NFCA-HepG2 thread structures to cover them fully. The threads were soaked
briefly in the collagen working solution and placed into a cell culture incubator for 30 minutes
to allow collagen gel formation. After incubation, the threads were transferred into non-
treated low attachment culture plates for HepG2 or SK-HEP-1 cell seeding. Cells were de-
tached and suspended in 2 ml of full cell culture medium (1.2  106 cells per ml). The cell sus-
pension was introduced on top of the NFCA or NFCA-HepG2 threads and incubated for 2
hours. During the 2-hour incubation period the well plates were subsequently shaken every 30
minutes to facilitate cell attachment on the thread surface. After cell seeding, the well plates
were placed into 37˚C in 5% CO2 and incubated from 48 hours and up to 2 weeks until confo-
cal imaging (n = 6 per each cell line). Cell culture medium was replaced every 48 hours.
Suture coating with NFCA-cell mixtures
Surgical sutures coated with NFCA were prepared prior to soft tissue suturing attempts. Biode-
gradable synthetic polyester surgical sutures (Velosorb™ Fast, 3–0, Covidien, USA) were coated
with NFCA-HepG2 mixtures using a syringe. The surgical suture was inserted through the
syringe barrel and needle orifice. The syringe was filled with NFCA-HepG2 mixture and fed
gently through the needle. The surgical suture was pulled at a slow rate to ensure the formation
of an even layer of the NFCA-cell mixture on the surface of the surgical suture (1.5  104 cells/
cm/suture). The readily coated sutures (n = 6) were transferred in crosslinking solutions as
described above to stabilize the NFCA coating. Directly after the crosslinking, each suture was
sewn through commercially bought pig liver sections three times and analyzed with confocal
microscopy. Suture weight was measured before and after the coating (AS 3Y Analytical Bal-
ance, Radwag, Poland; n = 5).
Confocal microscopy
NFCA threads and related cell studies were examined and analyzed with confocal microscopy
(Leica TCS SP5II HCS A, Leica Microsystems, Germany). Images were taken with HC PL
APO 10x/0.4 objective using Red (HeNe 633 nm/12mW) and Lime (DPSS 561 nm/20mW)
lasers with PTM detectors. Live/Dead imaging was performed with fluorescein diacetate
(FDA) and propidium iodide (PI) cellular stains (Molecular Probes1, USA) for live and dead
cells, respectively. Cell co-culture imaging was carried out with cellular dyes CellTracker™
Green CMFDA and Red CMTPX (Molecular Probes1, USA) for SK-HEP-1 and HepG2 cells,
respectively. Suture and NFCA coating diameters (5 x 20 cm sutures) were measured using
Leica LAS AF lite imaging suite (Leica Microsystems, Germany). 2 random positions were
selected from each coated suture and diameter measured (n = 10).
Suture performance ex vivo small-animal study
The small-animal ex vivo suture performance study was performed as a contract service by
Made Consulting (Toxicology Partners, preclinical services, Finland), and approved by the
Finnish National Animal Experiment Board and performed in accordance with the Animal
Welfare Act (247/1996) according to the laws of Finland. Two BALB/c mice and a Wistar rat
were sacrificed using a standard carbon dioxide chamber euthanasia method, and used to eval-
uate the performance of the surgical sutures coated with NFCA. Sutures were coated with
NFCA and cross-linked as described above. Target soft tissue was sutured and instrument type
knots were performed to complete the sutures (n = 14). Mouse liver, spleen, intestine, muscle
and skin in addition to rat intestine, testis and skin were selected for the performance testing.
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Results
NFCA hydrogel rheological properties
The prepared NFCA threads were able to withstand handling during the cell studies and sur-
gical suture coating experiments with soft tissue sutures. Rheological measurements were
conducted to observe how sodium alginate content affected the properties of the hydrogel.
Viscosity and shear thinning are important factors for hydrogel injectability, and changes in
storage and loss moduli could affect cell behavior, such as morphology. Frequency sweep mea-
surements of storage and loss moduli were plotted as a function of angular frequency (Fig 1).
The storage moduli were greater than loss moduli for all samples, and the loss tangent ranged
0.13–0.36 for NFC and approximately 0.29–0.49 for other samples. This suggests an elastic net-
work structure of hydrogels. NFCA samples showed roughly 6-8-fold higher storage and loss
moduli values, strengthening the hydrogel mixture network when compared to native NFC.
This was due to the addition of alginate, which additionally enabled crosslinking with cationic
salt treatment. As far as we know, this is the first time a non-breakable and flexible NFCA
hydrogel coated thread has been prepared for surgical purposes.
The viscosity increased significantly, when sodium alginate was included (Fig 2). Shear
thinning was observed on all hydrogel samples, and a similar decline in viscosity values was
seen when shear rate was gradually increased. This indicates similar shear thinning properties
of the native NFC and NFCA hydrogels. The amount of alginate had some impact in the vis-
cosity values when comparing changes within 1% increments, however 9% alginate content
showed nearly double the value (44%) when observed against the 7% NFCA mixture.
NFCA cell studies
Two different cell lines were selected to model 3D spheroid formation and monolayer growth
within the wire and on the surface respectively. These cell lines (HepG2 and SK-HEP-1) repre-
sented different cell types that could be utilized in cell delivery via the surgical thread.
NFCA threads were seeded with hepatocellular carcinoma HepG2 cells and incubated for
up to 2 weeks. Live/dead confocal microscopy images showed near 100% cell viability within
and on the surface of the NFCA threads, and only a few dead cells (< 1%) were observed
within the thread in both 1-week and 2-week incubation periods (Fig 3).
No dead cells were found on surface seeded NFCA threads; however, some variation in cell
growth properties was observed depending on the seeding site. HepG2 cells on the surface
showed typical cluster like growth and hepatic morphology. Cells seeded within the threads
were observed to grow individually or only in small clusters. Dead cell staining was verified by
killing the culture with a 70% ethanol treatment before confocal microscopy showing a 100%
rate for dead cells S1 Fig.
HepG2 cells were seeded within and on the surface of the threads and incubated for 72
hours (Fig 4A and 4B). Similarly, to the live/dead viability experiment, cells within the thread
grew individually or in small clusters containing only a few cells. Cells on the surface showed
strong growth of hepatic-type clusters, typical for the HepG2 cell line.
Another human adenocarcinoma-derived endothelial cell line (SK-HEP-1) was added to
investigate the NFCA thread co-culture surface growth properties. SK-HEP-1 cells were seeded
on the surface of the NFCA threads in addition to the HepG2 cells within the threads and incu-
bated for 48 hours. As opposed to the cluster like HepG2 morphology, SK-HEP-1 cell growth
showed epithelial-like morphology which is typical for the endothelial SK-HEP-1 cell line (Fig
4C and 4D). However, it should be noted that without collagen coating neither SK-HEP-1 nor
Nanofibrillar cellulose-alginate hydrogel coated surgical sutures as cell-carrier systems
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Fig 1. Frequency sweeps of NFCA samples. A) Storage modulus (G’) and B) loss modulus (G”) values showed
increased strength in the NFCA network with the addition of alginate. NFCA hydrogels were relatively independent of
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HepG2 adhered properly on the surface of bare NFCA threads. Collagen coating was not
required for cells that were entrapped within NFCA.
NFCA coated surgical sutures
HepG2 cells were seeded within the NFCA mixture, extruded through a syringe needle as a
layer on the surface of standard absorbable surgical sutures (Fig 5B) and incubated for 72
hours. HepG2 growth was shown, as previously observed, as small clusters or individual cells
(Fig 5A). NFCA-HepG2 coating was shown as an even layer on top of the suture; however,
slight inconsistencies were found when examining the thickness of the coating around the
suture. According to the United States Pharmacopeia (USP), the diameter of a standard 3–0
absorbable suture is 200 μm. Surrounding the suture, the average NFCA coated suture thick-
ness was measured at 297±25 μm in diameter (n = 10). Average weight of the threads (n = 5)
before and after coating were 0.86±0.04 mg/cm and 1.96±0.27 mg/cm respectively, a total
increase in weight of 1.1 mg/cm for the coated suture. The extruded pure NFCA hydrogel
required a force from the plunger, therefore, the product of a thread like hydrogel was thicker
(a total diameter of 550–600 μm; n = 5) than the coated sutures. The NFCA coating fabrication
did not require any force from the plunger as the suture was pulled through the nozzle; there-
fore, producing thinner coatings than the NFCA hydrogel threads themselves without the
suture.
angular frequency, which indicates a more stable gel structure as opposed to native NFC, where the values shift towards
higher frequencies.
https://doi.org/10.1371/journal.pone.0183487.g001
Fig 2. Viscosity measurements of NFC and NFCA samples. Addition of alginate increases the viscosity of
the hydrogel composition. A minor increase can be observed with the incremental addition of alginate content
within the mixture.
https://doi.org/10.1371/journal.pone.0183487.g002
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The NFCA-HepG2 coated sutures were used to simulate sewing three times through small
segments of pig liver. The coating remained intact on top of the suture thread after sewing (Fig
5A). Additionally, HepG2 cells were confirmed alive within the coating with confocal micros-
copy. The NFCA-HepG2 coating could be removed or peeled off as tube-like long segments
with the entire NFCA structure intact, indicating that the cells were entrapped within the coat-
ing matrix (Fig 5C).
NFCA thread sutures on ex vivo small-animal tissue
NFCA coating of standard absorbable surgical sutures were performed as described above.
Sutures were cross-linked with calcium chloride and barium chloride before attempting to
Fig 3. Live/Dead confocal imaging of NFCA-HepG2 threads stained with FDA (alive/green) and PI (dead/red). A) HepG2 cells were mixed within the
NFCA before crosslinking; after 1-week of incubation and C) after 2 weeks of incubation. B) HepG2 cells were seeded on top of type-I collagen treated
NFCA threads; after 1-week of incubation and D) after 2 weeks of incubation. An increase in the number of cells after the 2-week incubation period was not
observed when the cells were mixed within the NFCA material. However, HepG2 clusters were growing on the surface cultures. Only a few dead cells were
observed during the study period.
https://doi.org/10.1371/journal.pone.0183487.g003
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suture various internal organs and tissues of freshly sacrificed mice and a rat. The fabricated
threads felt slightly more rigid than a standard thread when performing the suturing
Fig 4. Confocal imaging of HepG2 and SK-HEP-1 cells stained with CTred and CTgreen, both markers for live cells. Type-I collagen treated NFCA
threads with HepG2 cells mixed within the material (red staining/HepG2 cells within the thread). A-B) HepG2 cells seeded on the surface of the NFCA threads
and incubated for 72h (green). C-D) SK-HEP-1 cells seeded on the surface of the NFCA threads and incubated for 48h (green). HepG2 cells within the
threads grew individually or in very small clusters; however, surface growth showed typical cluster and epithelial morphology of HepG2 and SK-HEP-1
respectively.
https://doi.org/10.1371/journal.pone.0183487.g004
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operation. Mouse and rat soft tissues: spleen, liver and muscle tissue S2 Fig, in addition to
intestine and skin (Fig 6) were sutured (n = 14). Instrument knot tying was performed to com-
plete the sutures on all tissue samples.
Two sutures from a total of 14 attempts showed slight peeling off in the NFCA coating.
Failed sutures were noticed during the attempts, as the detached coating segments were appar-
ent to the naked eye. However, 12 attempts were successful and knot tying was performed on
sample tissues without any peeling off (Fig 6). Peeling off was observed on one rat intestine
and one skin suture sample and none on mice.
Fig 5. Confocal imaging and preparation of NFCA-HepG2 coated surgical sutures. Live staining of CTred was
performed after 72 h incubation. A) Sutures coated with NFCA-HepG2 and sewn three times through a pig liver segment
indicating live HepG2 cells within the coating matrix. B, D) Preparation method of NFCA coated sutures. C) NFCA-HepG2
coating could be peeled off from the surgical suture as intact segments without damaging its tube-like structure showing live
HepG2 cells remaining within the coating.
https://doi.org/10.1371/journal.pone.0183487.g005
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Discussion
The NFCA threads were relatively easy to handle after crosslinking and could be bent and
made into knots without breaking apart, as our group has previously reported that glutaralde-
hyde crosslinking made NFC threads slightly more brittle [32]. Hydrogel was injectable at
7–9% alginate concentrations. The addition of alginate showed an increase in both loss and
storage moduli strengthening the hydrogel network roughly by one order of magnitude. The
ratio of the moduli remained similar to the native NFC hydrogel, suggesting that the NFCA
mixture retained its elastic properties. Mechanically the native NFC hydrogel resembles a
Fig 6. NFCA coated suture performance testing on small-animal tissues. Suturing was completed with instrument type knots. 12 out of 14 successful
sutures were performed on mouse and rat skin (A and B) in addition to rat intestine (C). Some peeling off was observed in 2 sutures during the performance
testing (D). Failed sutures were clearly visible and easily noticed as long tube-like segments (D).
https://doi.org/10.1371/journal.pone.0183487.g006
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collagen network, thereby providing good conditions for cell culture [9,15]. Rheological mea-
surements showed that the effect on increasing the alginate content from 8% to 9% was minor
in terms of gel strength and viscosity. However, the addition of alginate did improve the gel
composition and enabled crosslinking. Viscosity values were 77%, 83% and 87% higher with
7%, 8% and 9% NFCA’s respectively than with NFC alone. A similar increase was observed
with storage and loss moduli values. For example, the 8% NFCA shows an increase in storage
modulus from low to high frequencies at 87% and 100% respectively. Alginate content lower
than 7% would probably result in a weaker hydrogel composition and therefore be unfit for
suture coating fabrication. Additionally, alginate stabilized the hydrogel structure which can
be seen from the frequency sweep measurements as the NFCA hydrogels were relatively inde-
pendent of the angular frequency at investigated ranges as opposed to NFC alone at higher fre-
quencies, where some curve shifting could be observed. Further addition of alginate (over 9%)
made injectability problematic and the final amount of 8% (w/v) alginate content was found to
be optimal in terms of strength and the thread fabrication process itself. Therefore, according
to the rheological results and injectability, the coating composition of 1.35% NFCA and 8%
alginate content was used with the cell culture studies and the suture performance tests.
HepG2 cells maintained almost 100% viability as shown in the confocal images. Cell mor-
phology showed limited hepatic cluster like growth when entrapped within the thread matrix,
probably due to the restricted space within the dense NFCA network. However, the cells were
stable and viable for up to 2 weeks of culturing, indicating a proper flow of nutrients and gas
exchange. Typical hepatic spheroid formation within the thread would probably require a
more dilute NFC mixture, as shown previously [10,43]. However, the lower viscosity should be
addressed to compensate the loss of strength from the increasing amount of water content.
HepG2 cells seeded on the surface of the thread showed a distinguished hepatic morphology
and growth in clusters that increased in size during the 2-week study period. For surface cul-
ture, collagen treatment was necessary. Without collagen, the cells did not adhere properly on
the surface of NFCA. Therefore, modifications are required for surface cell attachment. To
avoid the use of collagen, this could be solved by, for example, including cell-adhesion peptides
in the NFC matrix [44].
Model co-cultures performed with dual HepG2 and SK-HEP-1/HepG2 cultures expressed
their typical respective morphologies correctly depending on the cell type. SK-HEP-1/HepG2
co-cultures were examined after the 48-hour incubation period and the formation of a mono-
layer was easily distinguished on the surface of the NFCA threads. However, due to the
restricted incubation period, which was limited by the imaging timeframe of the cellular dye,
SK-HEP-1 monolayer was not fully confluent. Longer incubation periods or NFCA modifica-
tions could improve cell attachment to achieve better confluence. For example, an effective
bioconjugation method has been shown to improve cell-adhesion of nanofibrillar cellulose
surfaces [45]. Therefore, NFCA threads have potential as cell-carrier systems for cell-based
therapy, such as wound-healing platforms, where cell migration could be mediated from the
suture to integrate the post-surgical treatment into the surgical process. Cell delivery can be
facilitated from within the thread, forming a protective layer to improve cell viability and
decrease unwanted cell distribution, or alternatively from the thread surface for more immedi-
ate cellular interactions. Additionally, with this finding we have shown that the NFCA threads
enable multiple types of cells to be delivered simultaneously to the target site.
Coating surgical sutures with NFCA was shown to be a simple and reproducible process.
The total hydrogel coated suture thickness was measured at 297±25 μm (n = 10), which corre-
sponds closely with the USP designated diameter for a standard 2–0 synthetic absorbable
suture (300 μm). Variation in diameter of all coated sutures was 8.2% of total diameter, which
was small enough to enable suturing successfully with 12 out of 14 attempts. Average weight of
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the threads before and after coating were 0.86±0.04 mg/cm and 1.96±0.27 mg/cm respectively,
which results in a small total increase in weight of 1.1 mg/cm in comparison of uncoated and
coated sutures. As an example, a full 36-inch single coated suture would only weigh approxi-
mately 100.1 mg more than a suture without the coating. Therefore, the total weight increase
was not very significant. HepG2 cells were shown viable within the coating material during the
72-hour incubation period as expected from the previous 2-week NFCA thread viability
results. It was noticed that the polyester suture had affinity to the dye which was shown clearly
after the coating was removed from the suture. Suture coating could be peeled off as large
intact tube like segments while entrapping the cells within. This suggests that the tube remains
at the target site after suture degradation, prolonging the cellular activity. The fabrication
method enables the entire coating of a suture; however, the small variation in thickness may
cause the coating to peel off in addition to choosing the correct needle. 2–0 compatible needles
should be used to compensate the coated 3–0 diameter.
Small-animal suture performance tests showed peeling off on two samples (rat skin and
intestine) from a total of 14 attempts. Variations in thickness during the coating process or
incorrect needle size could cause the coating to get stuck in the tissue at the beginning of the
suturing operation; especially with more penetration resistant tissues, such as the skin. The
synthetic poly lactic-co-glycolic acid (PLGA) co-polymer sutures used in this study have been
reported to have hydrophobic properties [46]. Hydrophobic sutures could present problems
with the high water content of the NFCA coating. The hydrophobicity of the synthetic PLGA
sutures could explain the observed peeling off effect as large intact tube like segments. Other
types of sutures (i.e. less hydrophobic) should improve the performance of the coating mate-
rial. However, 12 sutures were performed successfully with various tissues including instru-
ment type knots to close the sutures. Furthermore, the NFCA thread coatings were flexible
and strong enough to enable and withstand the mechanical stress of the suturing process itself
without breaking apart, from the beginning of the operation to the closing of the knot at the
end of each suture.
The NFCA coated sutures have potential to combine treatment with surgical suturing
where cell therapy is viable, removing the need for additional injections of cells to target sites
or into the sutures themselves, which can result in suboptimal viability and uncontrolled cell
distribution, especially with unprotected cell seeded sutures [4]. The number of cells could be
controlled by the concentration of cells within the coating in thread thickness and length, in
addition to protection and enhanced target cell delivery. The optimal number of cells in cellu-
lar delivery depends on its application; our experiments were done with 1.5  104 cells/cm/
suture. In comparison to sutures seeded with cells, a study for cardiac therapy after infarcted
myocardium contained 5.9  103 cells/cm/suture [3], and in a study for post-operative compli-
cations after tracheal surgery contained 4.0  104 cells/cm and 1.3  104 cells/cm [47].
However, while the native NFC is non-toxic and biocompatible, the biodegradability in the
body is a concern; therefore, additional modifications could be made into the NFC structure to
enable self-degradation. Alternatively, embedding the surgical suture, or the NFCA matrix itself,
with cellulases, which have proven to be effective in degrading NFC and have not shown cyto-
toxic effects in stem cells [10]. In addition, commonly used polymers in sutures provide slightly
acidic conditions as they degrade into lactic or glycolic acids [48], which would improve cellu-
lase enzyme performance as their relative activity increases with lower pH [49]. However, the
absorbable suture is biodegradable and Velosorb, according to the manufacturer, loses its total
tensile strength within 2 weeks post-surgery, a time period which the cells can easily survive
according to our findings in this study. Additionally, the cross-linked alginate will dissolve with
the release of divalent Ca2+ and Ba2+ ions [23], therefore, eventually loosening the system and
allowing the cells to distribute and interact with the surrounding tissue directly.
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According to our findings, we propose that NFCA coated surgical sutures are viable on eas-
ily accessible areas, such as the skin and other surfaces where the removal of NFC would not
cause further complications, i.e. the gastrointestinal tract, where the rapid renewal rate and
motility would eventually remove traces of NFC. NFCA coated sutures show potential as cell-
carrier systems integrated with surgical suture processes; however small-animal tissue compo-
sition and structure varies from human tissue and requires further investigation.
Conclusions
We have demonstrated a method of producing NFCA threads and surgical suture coatings
including single type cell cultures and co-cultures simultaneously within and on the surface of
NFCA that are viable for up to 2 weeks. Cells on the surface show typical morphologies of their
respective types (i.e. cluster and monolayer); cells inside the thread were observed as smaller
clusters. Rheological measurements of NFCA showed similar viscoelastic properties when
compared to the native NFC, which has been shown to support good cell culture conditions as
the structural properties resemble the physiological conditions of a soft tissue collagen net-
work. Hydrogel strength was improved with the addition of alginate to form proper suture
coatings. 12 out of 14 surgical sutures coated with NFCA performed well with various mouse
and rat tissue. In 2 sutures, peeling off of NFCA was observed. With cell-carrier suture systems,
additional injections could be avoided while still introducing the cells into the diseased tissue.
NFCA coating acts as a biomaterial for cellular growth and protection, while controlling the
number of cells within. Multiple types of surgical sutures could be used for cell entrapment as
coating applications. We believe that cell-carrier systems, such as the NFCA suture coatings,
would address some of the issues in therapeutic cell delivery, such as reducing undesired cell
migration, aggregation and low survivability. In addition, the coating method allows co-cul-
tures within the same suture, which could prove beneficial in future cellular therapies.
Supporting information
S1 Fig. HepG2 cells seeded on top of NFCA hydrogels and stained with live (green) and red
(dead). A) Confocal imaging after 1-week incubation. B) 1-week incubation, HepG2 cells
killed with 70% ethanol. C,D) Confocal images after 2-week incubation period showing large
hepatic clusters.
(TIF)
S2 Fig. NFCA coated suture performance on freshly sacrificed mice. Mouse liver (top),
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Data curation: Patrick Laurén, Irina Pitkänen.
Formal analysis: Patrick Laurén, Petter Somersalo, Irina Pitkänen, Mari Madetoja, Timo
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serves three-dimensional spheroid structures of human pluripotent stem cells and HepG2 cells. Sci Rep
2015; 5:13635. https://doi.org/10.1038/srep13635 PMID: 26323570
14. Malinen MM, Palokangas H, Yliperttula M, Urtti A. Peptide nanofiber hydrogel induces formation of bile
canaliculi structures in three-dimensional hepatic cell culture. Tissue Eng Part A. 2012; 23–24: 2418–
25.
15. Miron-Mendoza M, Seemann J, Grinnell F. The differential regulation of cell motile activity through
matrix stiffness and porosity in three dimensional collagen matrices. Biomaterials. 2010; 31: 6425–
6435. https://doi.org/10.1016/j.biomaterials.2010.04.064 PMID: 20537378
16. Missoum K, Belgacem MN, Bras J. Nanofibrillated Cellulose Surface Modification: A Review. Materials.
2013; 6: 1745–66.
17. Eichhorn SJ, Dufresne A, Aranguren M, Marcovich NE, Capadona JR, Rowan SJ, et al. Review: current
international research into cellulose nanofibres and nanocomposites. J Mat Sci. 2010; 45: 1–33.
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